Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Neoplasms 2Breast Neoplasms 2Agnosia 2Rectal Neoplasms 1Malignant Neoplasms of Male Genital Organs 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Ketamine 3Sodium Chloride 2Ropivacaine 2Propofol 2Analgesics, Opioid 2Analgesia, Patient-Controlled 2parecoxib 1Tea 1Tapentadol 1Surveys and Questionnaires 1Sevoflurane 1Saline Solution 1Lidocaine 1Ketorolac 1Ibuprofen 1Epinephrine 1Dexamethasone 1Codeine 1Clonidine 1Circumcision, Male 1Celecoxib 1Anesthesia, General 1Acupuncture Therapy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Agnosia × Propofol × Clear all
NCT00418457 2020-06-16

Regional Anesthesia and Breast Cancer Recurrence

The Cleveland Clinic

Phase 3 Completed
2,108 enrolled 12 charts
Breast

Agnosia, Breast Neoplasms

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn
Gynecologic

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡